Outcomes of 5-Year Survivors of Pediatric Liver Transplantation: Report on 461 Children From a North American Multicenter Registry

OBJECTIVES. Although liver transplantation has been the standard of care therapy for life-threatening liver diseases for >20 years, data on the long-term impact of liver transplantation in children have been primarily limited to single-center experiences. The objective of this study was to characterize and evaluate the clinical course of children who have survived ≥5 years after pediatric liver transplantation in multiple centers across North America. PATIENTS AND METHODS. Patients enrolled in the Studies of Pediatric Liver Transplantation database registry who had undergone liver transplantation at 1 of 45 pediatric centers between 1996 and 2001 and survived >5 years from liver transplantation were identified and their clinical courses retrospectively reviewed. RESULTS. The first graft survival for 461 five-year survivors was 88%, with 55 (12%) and 10 (2%) children undergoing a second and third liver transplantation. At the 5-year anniversary clinic visit, liver function was preserved in the majority with daily use of immunosuppression therapy, including a calcineurin inhibitor and oral prednisone, reported by 97% and 25% of children, respectively. The probability of an episode of acute cellular rejection occurring within 5 years after liver transplantation was 60%. Chronic rejection occurred in 5% patients. Posttransplant lymphoproliferative disease was diagnosed in 6% children. Calculated glomerular filtration rate was <90 mL/minute per 1.73 m2 in 13% of 5-year survivors. Age- and gender-adjusted BMI >95th percentile was noted in 12%, with height below the 10th percentile in 29%. CONCLUSIONS. Children who are 5-year survivors of liver transplantation have good graft function, but chronic medical conditions and posttransplantation complications affect extrahepatic organs. A comprehensive approach to the management of these patients' multiple unique needs requires the expertise and commitment of health care providers both beyond and within transplant centers to further optimize long-term outcomes for pediatric liver transplant recipients.

[1]  A. Dhawan,et al.  Are children after liver transplant more prone to non‐alcoholic fatty liver disease? , 2008, Pediatric transplantation.

[2]  E. Alonso.  Growth and developmental considerations in pediatric liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  J. Magee,et al.  Pediatric Transplantation in the United States, 1997–2006 , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  V. Ng,et al.  Liver Retransplantation in Children: A SPLIT Database Analysis of Outcome and Predictive Factors for Survival , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  T. Starzl.  Immunosuppressive therapy and tolerance of organ allografts. , 2008, The New England journal of medicine.

[6]  J. Millis,et al.  Impact of Graft Type on Outcome in Pediatric Liver Transplantation: A Report From Studies of Pediatric Liver Transplantation (SPLIT) , 2007, Annals of surgery.

[7]  Johnny C. Hong,et al.  Predictors of Outcomes after Pediatric Liver Transplantation: An Analysis of More Than 800 Cases Performed at a Single Institution , 2007 .

[8]  S. Guthery,et al.  Outcomes After Liver Transplantation: Keep the End in Mind , 2006, Journal of pediatric gastroenterology and nutrition.

[9]  M. Guidinger,et al.  Pediatric Transplantation in the United States, 1995–2004 , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  S. Hübscher,et al.  Progressive histological damage in liver allografts following pediatric liver transplantation , 2006, Hepatology.

[11]  G. Tiao,et al.  High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. , 2006, The Journal of pediatrics.

[12]  Steven R. Martin,et al.  Normal Glomerular Filtration Rate in Long-Term Follow-up of Children after Orthotopic Liver Transplantation , 2006, Transplantation.

[13]  G. Mazzucco,et al.  Posttransplantation chronic renal damage in nonrenal transplant recipients. , 2005, Kidney international.

[14]  G. Berenson,et al.  Cardiovascular risk factors in youth with implications for aging: The Bogalusa Heart Study , 2005, Neurobiology of Aging.

[15]  D. Grant,et al.  Health Status Ten Years After Pediatric Liver Transplantation—Looking Beyond The Graft , 2004, Transplantation.

[16]  R. Wolfe,et al.  Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[17]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[18]  W. Bechstein,et al.  Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. , 2003, Transplantation.

[19]  J. Otte.  History of pediatric liver transplantation. Where are we coming from? Where do we stand? , 2002, Pediatric transplantation.

[20]  A. González-Quintela,et al.  Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. , 2002, Transplantation proceedings.

[21]  W. Wall,et al.  Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[22]  T. Starzl,et al.  Pediatric liver transplantation. A single center experience spanning 20 years. , 2002, Transplantation.

[23]  A. Green,et al.  γ-Glutamyltransferase: value of its measurement in paediatrics , 2002, Annals of clinical biochemistry.

[24]  S. McDiarmid.  Update from studies in pediatric liver transplantation. , 2001, Transplantation proceedings.

[25]  J. Mir,et al.  Are posttransplantation protocol liver biopsies useful in the long term? , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  Steven R. Martin,et al.  STUDIES OF PEDIATRIC LIVER TRANSPLANTATION (SPLIT): YEAR 2000 OUTCOMES , 2001, Transplantation.

[27]  G. Mazariegos,et al.  Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation , 2001, Pediatric transplantation.

[28]  S. E. Thomas,et al.  Linear growth after pediatric liver transplantation. , 1999, The Journal of pediatrics.

[29]  T. Cole,et al.  Growth of long term survivors of liver transplantation , 1999, Archives of disease in childhood.

[30]  M. Maggard,et al.  Long-term results of pediatric liver transplantation: an analysis of 569 transplants. , 1998, Annals of surgery.

[31]  P. Rosenthal,et al.  Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[32]  J. Sommerauer,et al.  10 years of pediatric liver transplantation. , 1996, Journal of pediatric surgery.

[33]  R. Busuttil,et al.  A randomized prospective trial of steroid withdrawal after liver transplantation. , 1995, Transplantation.

[34]  A. Demetris,et al.  Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. , 1995, The American journal of surgical pathology.

[35]  P. Whitington,et al.  Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. , 1991, The Journal of pediatrics.

[36]  J. Hiatt,et al.  Liver transplantation in children , 1991, Annals of surgery.

[37]  R. Lauer,et al.  The relation between ponderosity and coronary risk factors in children and their relatives. The Muscatine Ponderosity Family Study. , 1989, American journal of epidemiology.

[38]  M. Walser,et al.  Creatinine measurements often yielded false estimates of progression in chronic renal failure. , 1988, Kidney international.

[39]  J P Kriss,et al.  Limitations of creatinine as a filtration marker in glomerulopathic patients. , 1985, Kidney international.

[40]  G. Schwartz,et al.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. , 1976, Pediatrics.

[41]  Ghory Je.  CHILDREN'S MEDICAL CENTER. , 1964 .

[42]  J. Morgan.  HOSPITAL FOR SICK CHILDREN. , 1884 .

[43]  M. Burdelski,et al.  Liver transplantation in children: long-term outcome and quality of life , 1999, European Journal of Pediatrics.

[44]  R. Hawkins,et al.  The impairment of true glomerular filtration rate in long-term cyclosporine-treated pediatric allograft recipients. , 1990, Transplantation.

[45]  National Institutes of Health Consensus Development Conference Statement: Liver2 Transplantation‐June 20–23, 1983 , 1984, Hepatology.